The role of alternative splicing in cancer: From oncogenesis to drug resistance
2020 · Drug Resistance Updates · 302 citations
https://doi.org/10.1016/j.drup.2020.100728
A
Anna Wojtuszkiewicz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
937
Citations
14
h-index
15
i10-index
Anna Wojtuszkiewicz is an academic researcher from Genmab (Netherlands). The author has contributed to research in topics: RNA Research and Splicing & RNA modifications and cancer & Acute Lymphoblastic Leukemia research. The author has an h-index of 14, co-authored 24 publications.
ORCID: 0000-0002-4018-8840Papers by this author
worksExosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis
2016 · Molecular & Cellular Proteomics · 88 citations
https://doi.org/10.1074/mcp.m115.052944
Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
2015 · Journal of Hematology & Oncology · 75 citations
https://doi.org/10.1186/s13045-015-0158-9
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
2021 · Leukemia · 0 citations
https://doi.org/10.1038/s41375-021-01340-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat